Home  |  Contact

Cellosaurus KY-ADR2 (CVCL_Z940)

Cell line name KY-ADR2
Accession CVCL_Z940
Resource Identification Initiative To cite this cell line use: KY-ADR2 (RRID:CVCL_Z940)
Comments Selected for resistance to: ChEBI; CHEBI:28748; Doxorubicin (Adriablastin; Adriamycin).
Derived from sampling site: Meninges.
Disease Acute myelomonocytic leukemia (NCIt: C7463)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Parent: CVCL_1346 (KY821)
Sex of cell Male
Age at sampling 28Y
Category Cancer cell line

PubMed=7934146; DOI=10.1016/0145-2126(94)90071-X
Fukuda T., Kakihara T., Kamishima T., Ohnishi Y., Naito M., Kishi K., Shibata A., Tsuruo T.
Characterization of newly established adriamycin resistant human leukemic cell lines (KY-ADR1 and KY-ADR2).
Leuk. Res. 18:709-715(1994)

PubMed=12716468; DOI=10.1111/j.1349-7006.2002.tb01336.x
Shimizu H., Fukuda T., Ghazizadeh M., Nagashima M., Kawanami O., Suzuki T.
Molecular cytogenetic characterization of drug-resistant leukemia cell lines by comparative genomic hybridization and fluorescence in situ hybridization.
Jpn. J. Cancer Res. 93:902-910(2002)

Other Wikidata; Q54900769